Wedbush Securities Inc I Bio, Inc. Transaction History

Wedbush Securities Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 20, 2020	SELL	$1.7 - $6.41 $32,300 - $121,790	-19,000 Closed	0 $0
Q2 2020 Jul 16, 2020	BUY	$0.87 - $2.46 $16,530 - $46,740	19,000 New	19,000 $42,000
Q4 2019 Jan 16, 2020	SELL	$0.11 - $0.58 $4,356 - $22,971	-39,606 Closed	0 $0
Q3 2019 Oct 17, 2019	BUY	$0.54 - $0.89 $10,692 - $17,622	19,801 Added 99.98%	39,606 $21,000
Q2 2019 Aug 01, 2019	BUY	$0.71 - $0.91 $14,061 - $18,022	19,805 New	19,805 $14,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.